Leptin Administration Favors Muscle Mass Accretion by Decreasing FoxO3a and Increasing PGC-1alpha in Ob/ob Mice

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2009 Sep 5

PMID 19730740

Citations 67

Authors

Neira Sainz

Amaia Rodriguez

Victoria Catalan

Sara Becerril

Beatriz Ramirez

Javier Gomez-Ambrosi

Gema Fruhbeck

Affiliations

Soon will be listed here.

Abstract

Absence of leptin has been associated with reduced skeletal muscle mass in leptin-deficient ob/ob mice. The aim of our study was to examine the effect of leptin on the catabolic and anabolic pathways regulating muscle mass. Gastrocnemius, extensor digitorum longus and soleus muscle mass as well as fiber size were significantly lower in ob/ob mice compared to wild type littermates, being significantly increased by leptin administration (P<0.001). This effect was associated with an inactivation of the muscle atrophy-related transcription factor forkhead box class O3 (FoxO3a) (P<0.05), and with a decrease in the protein expression levels of the E3 ubiquitin-ligases muscle atrophy F-box (MAFbx) (P<0.05) and muscle RING finger 1 (MuRF1) (P<0.05). Moreover, leptin increased (P<0.01) protein expression levels of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), a regulator of muscle fiber type, and decreased (P<0.05) myostatin protein, a negative regulator of muscle growth. Leptin administration also activated (P<0.01) the regulators of cell cycle progression proliferating cell nuclear antigen (PCNA) and cyclin D1, and increased (P<0.01) myofibrillar protein troponin T. The present study provides evidence that leptin treatment may increase muscle mass of ob/ob mice by inhibiting myofibrillar protein degradation as well as enhancing muscle cell proliferation.

Citing Articles

Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions.

Wang T, Zhou D, Hong Z MedComm (2020). 2025; 6(1):e70030.

PMID: 39764565 PMC: 11702502. DOI: 10.1002/mco2.70030.

Control of muscle satellite cell function by specific exercise-induced cytokines and their applications in muscle maintenance.

Guo Q, Luo Q, Song G J Cachexia Sarcopenia Muscle. 2024; 15(2):466-476.

PMID: 38375571 PMC: 10995279. DOI: 10.1002/jcsm.13440.

Incident low muscle mass is associated with greater lung disease and lower circulating leptin in a tobacco-exposed longitudinal cohort.

Zou R, Nouraie S, Karoleski C, Zhang Y, Sciurba F, Forman D Respir Res. 2023; 24(1):224.

PMID: 37737171 PMC: 10515430. DOI: 10.1186/s12931-023-02521-3.

Role of adipokines in sarcopenia.

Lu W, Feng W, Lai J, Yuan D, Xiao W, Li Y Chin Med J (Engl). 2023; 136(15):1794-1804.

PMID: 37442757 PMC: 10406092. DOI: 10.1097/CM9.0000000000002255.

The crosstalk between BAT thermogenesis and skeletal muscle dysfunction.

Chen Y, Hu Q, Wang C, Wang T Front Physiol. 2023; 14:1132830.

PMID: 37153220 PMC: 10160478. DOI: 10.3389/fphys.2023.1132830.

References

Lambert A, Wang B, Yardley J, Edwards J, Merry B . The effect of aging and caloric restriction on mitochondrial protein density and oxygen consumption. Exp Gerontol. 2004; 39(3):289-95. DOI: 10.1016/j.exger.2003.12.009. View

Eley H, Tisdale M . Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. J Biol Chem. 2007; 282(10):7087-97. DOI: 10.1074/jbc.M610378200. View

Harris R . Parabiosis between db/db and ob/ob or db/+ mice. Endocrinology. 1999; 140(1):138-45. DOI: 10.1210/endo.140.1.6449. View

Ramsay T . Porcine leptin inhibits protein breakdown and stimulates fatty acid oxidation in C2C12 myotubes. J Anim Sci. 2003; 81(12):3046-51. DOI: 10.2527/2003.81123046x. View

Wu A, Kim J, Zhang C, Unterman T, Chen J . Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components. Endocrinology. 2007; 149(3):1407-14. PMC: 2275355. DOI: 10.1210/en.2007-1470. View

Gomes M, Lecker S, Jagoe R, Navon A, GOLDBERG A . Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A. 2001; 98(25):14440-5. PMC: 64700. DOI: 10.1073/pnas.251541198. View

McPherron A, Lawler A, Lee S . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628):83-90. DOI: 10.1038/387083a0. View

Guerra B, Fuentes T, Delgado-Guerra S, Guadalupe-Grau A, Olmedillas H, Santana A . Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS One. 2008; 3(10):e3466. PMC: 2565105. DOI: 10.1371/journal.pone.0003466. View

Hu M, Lee D, Xia W, Golfman L, Ou-Yang F, Yang J . IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell. 2004; 117(2):225-37. DOI: 10.1016/s0092-8674(04)00302-2. View

10.

Sriwijitkamol A, Ivy J, Christ-Roberts C, DeFronzo R, Mandarino L, Musi N . LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training. Am J Physiol Endocrinol Metab. 2005; 290(5):E925-32. DOI: 10.1152/ajpendo.00429.2005. View

11.

Warmington S, Tolan R, McBennett S . Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse. Int J Obes Relat Metab Disord. 2000; 24(8):1040-50. DOI: 10.1038/sj.ijo.0801357. View

12.

Allen D, Cleary A, Speaker K, Lindsay S, Uyenishi J, Reed J . Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab. 2008; 294(5):E918-27. DOI: 10.1152/ajpendo.00798.2007. View

13.

Southgate R, Neill B, Prelovsek O, El-Osta A, Kamei Y, Miura S . FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J Biol Chem. 2007; 282(29):21176-86. DOI: 10.1074/jbc.M702039200. View

14.

Li M, Chiu J, Gagne J, Fukagawa N . Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells. J Cell Physiol. 2008; 217(2):377-87. PMC: 3681091. DOI: 10.1002/jcp.21507. View

15.

Kedar V, McDonough H, Arya R, Li H, Rockman H, Patterson C . Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci U S A. 2004; 101(52):18135-40. PMC: 539735. DOI: 10.1073/pnas.0404341102. View

16.

Sahu A . Minireview: A hypothalamic role in energy balance with special emphasis on leptin. Endocrinology. 2004; 145(6):2613-20. DOI: 10.1210/en.2004-0032. View

17.

Booth F, Kirby C . Changes in skeletal muscle gene expression consequent to altered weight bearing. Am J Physiol. 1992; 262(3 Pt 2):R329-32. DOI: 10.1152/ajpregu.1992.262.3.R329. View

18.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

19.

Sandri M, Lin J, Handschin C, Yang W, Arany Z, Lecker S . PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A. 2006; 103(44):16260-5. PMC: 1637570. DOI: 10.1073/pnas.0607795103. View

20.

Adams G . Satellite cell proliferation and skeletal muscle hypertrophy. Appl Physiol Nutr Metab. 2007; 31(6):782-90. DOI: 10.1139/h06-053. View